Contact this trialFirst, we need to learn more about you.
AhR Inhibitor
BAY 2416964 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Lake Mary, Florida
This trial is looking for a new way to treat cancer by using a drug to block a protein called Aryl Hydrocarbon Receptor (AhR). The study drug, BAY 2416964, is a small molecule which blocks the AhR allowing the body to use its immune response against the cancer cells. Researchers think that BAY 2416964 given together with a cancer treatment called pembrolizumab may help shrink tumors in people with cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.